Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids

NCT05128383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Keloid

Interventions

DRUG: Dupilumab

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]